scholarly journals Cost-Minimization Analyses of Adalimumab Compared with Selective Immunosuppressive Cytokines Blockers and Inhibitors of Tumor Necrosis Factor Alpha Indicated for the Treatment of Rheumatoid Arthritis, Psoriasis and Crohn’s Disease in the Private Market in Mexico

2015 ◽  
Vol 18 (7) ◽  
pp. A843
Author(s):  
CA Pichardo-Piña ◽  
JL Sánchez-Casillas ◽  
JC Pozos-Espíndola
Sign in / Sign up

Export Citation Format

Share Document